Publishing research using ab32083? Please let us know so that we can cite the reference in this datasheet.
ab32083 has been referenced in 7 publications.
- Zhang T et al. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3. Oncogene 36:6627-6639 (2017). PubMed: 28783167
- Peng YC et al. Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. Tumour Biol N/A:N/A (2016). Human . PubMed: 26886287
- Maeshima K et al. Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation. JCI Insight 1:N/A (2016). IHC ; Human . PubMed: 27275015
- Li K et al. Genome-Wide Transcriptional Analysis Reveals the Protection against Hypoxia-Induced Oxidative Injury in the Intestine of Tibetans via the Inhibition of GRB2/EGFR/PTPN11 Pathways. Oxid Med Cell Longev 2016:6967396 (2016). WB ; Human . PubMed: 27594973
- Zheng J et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat Genet 48:747-57 (2016). PubMed: 27213290
- Zheng J et al. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Tumour Biol N/A:N/A (2015). IHC ; Human . PubMed: 26695153
- Xie H et al. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol 117:234-42 (2014). WB . PubMed: 24439919